Literature DB >> 16423488

A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid.

Rodney C Arcenas1, James R Uhl, Seanne P Buckwalter, Andrew H Limper, Dana Crino, Glenn D Roberts, Nancy L Wengenack.   

Abstract

Pneumocystis jiroveci is an important cause of pneumonia in immunocompromised individuals. This organism cannot be cultured, and therefore, diagnosis relies on microscopic identification of the organism using stains or antibodies. Although simple, these tests are insensitive and require expertise for accurate interpretation. We developed a real-time polymerase chain reaction (PCR) assay that provides sensitive and objective detection of Pneumocystis from bronchoalveolar lavage fluid. Primers and fluorescence resonance energy transfer probes were developed that target the cdc2 gene of P. jiroveci. Assay sensitivity is 6 copies of target per microliter of sample. No cross-reactivity occurs with other pathogens, and the PCR assay has a 21% increase in clinical sensitivity as compared with Calcofluor white staining. The real-time PCR assay provides a sensitive, rapid, and objective method for the detection of Pneumocystis from bronchoalveolar lavage fluid.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423488     DOI: 10.1016/j.diagmicrobio.2005.08.006

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  22 in total

1.  Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients.

Authors:  Françoise Botterel; Odile Cabaret; Françoise Foulet; Catherine Cordonnier; Jean-Marc Costa; Stéphane Bretagne
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

Review 2.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

3.  Clinical Performance of (1,3) Beta-D Glucan for the Diagnosis of Pneumocystis Pneumonia (PCP) in Cancer Patients Tested With PCP Polymerase Chain Reaction.

Authors:  Sejal Morjaria; John Frame; Alexandra Franco-Garcia; Alexander Geyer; Mini Kamboj; N Esther Babady
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

4.  Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR.

Authors:  Lisa R McTaggart; Nancy L Wengenack; Susan E Richardson
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

5.  Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii on the fully automated BD MAX platform.

Authors:  Alexander H Dalpke; Marjeta Hofko; Stefan Zimmermann
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

6.  Inhibition controls for qualitative real-time PCR assays: are they necessary for all specimen matrices?

Authors:  S P Buckwalter; L M Sloan; S A Cunningham; M J Espy; J R Uhl; M F Jones; E A Vetter; J Mandrekar; F R Cockerill; B S Pritt; R Patel; N L Wengenack
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

7.  Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.

Authors:  Philippe M Hauser; Jacques Bille; Cornelia Lass-Flörl; Christian Geltner; Marta Feldmesser; Michael Levi; Hitesh Patel; Victoria Muggia; Barbara Alexander; Martin Hughes; Sarah A Follett; Xiaohui Cui; Flora Leung; Gillian Morgan; Adrian Moody; David S Perlin; David W Denning
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

8.  Incidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing Polymerase Chain Reaction-based diagnosis in patients with Hodgkin lymphoma.

Authors:  Jason N Barreto; Carrie A Thompson; Patrick M Wieruszewski; Amanda G Pawlenty; Kristin C Mara; Ashley L Potter; Pritish K Tosh; Andrew H Limper
Journal:  Leuk Lymphoma       Date:  2020-07-05

9.  (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.

Authors:  F Esteves; C-H Lee; B de Sousa; R Badura; M Seringa; C Fernandes; J F Gaspar; F Antunes; O Matos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-03       Impact factor: 3.267

10.  Detection of Pneumocystis jirovecii by two staining methods and two quantitative PCR assays.

Authors:  P Rohner; V Jacomo; R Studer; J Schrenzel; J-D Graf
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.